Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 3 (1), 2-11
eCollection

Stem Cell Therapy for Neuropathic Pain Treatment

Affiliations

Stem Cell Therapy for Neuropathic Pain Treatment

D Siniscalco et al. J Stem Cells Regen Med.

Abstract

Pain initiated or caused by a primary lesion or dysfunction in the nervous system is defined as neuropathic pain. About 75 -150 million people in the United States are suffering for chronic pain disorder. Neuropathic pain has a great impact on the human wellbeing. It is very debilitating and often has an associated degree of depression that contributes to decreasing the quality of life. Moreover, the management of chronic pain is costly to the health care system. Pain is a national healthcare priority in US: the United States Congress has declared the present decade (2001-2010) as the "Decade of Pain Control and Research". Neuropathic pain is a very complex disease, involving several molecular pathways. Due to its individual character, its treatment is extremely difficult. Current available drugs are usually not acting on the several mechanisms underlying the generation and propagation of pain. Nowadays, pain research is focusing on newer molecular ways, such as stem cell therapy, gene therapy, and viral vectors for delivery of biologic anti-nociceptive molecules. These methods could provide a new therapeutic approach to neuropathic pain relief.

Keywords: gene therapy; neuropathic pain; stem cell therapy; virus vector.

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

References

    1. Merskey H, Bogduk N. Classification of chronic pain. IASP press, Seattle, 1994
    1. Siniscalco D, de Novellis V, Rossi F, Maione S. Neuropathic pain: is the end of suffering starting in the gene therapy. Curr Drug Targets. 2005; 6: 75-80 - PubMed
    1. de Novellis V, Siniscalco D, Galderisi U, Fuccio C, Nolano M, Santoro L, Cascino A, Roth KA, Rossi F, Maione S. Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II. Neuropharmacology 2004; 46: 468-479 - PubMed
    1. Bonica JJ. In Advances in Pain Research and Therapy. Raven Press, New York, 1970, ppl41-166
    1. Kandel E.R, Schwartz JH, Jessel TM. In Principles of Neural Science. McGraw-Hill, New York, 4th ed. 2000

LinkOut - more resources

Feedback